Enterprise Limited's (
AHEL) board on Monday announced a sweeping corporate overhaul, approving a composite scheme of arrangement involving its subsidiaries Apollo Healthco Limited (AHL) and Keimed Private Limited, alongside its wholly owned subsidiary Apollo Healthtech Limited.Under the restructuring exercise, the company will first demerge its 'Identified Business Undertaking' into Apollo Healthtech. Subsequently, both AHL and Keimed Private Limited will be merged into Apollo Healthtech, consolidating critical operations under one roof.
Through this move, AHEL aims to unlock value through strategic reorganisation, enabling direct listing of its Omni Channel Pharmacy and Digital Health business, a company filing to the exchanges said.
"Composite Scheme creates a formidable Omni Channel Pharmacy Distribution and Digital Health platform leader in India, with scale of Rs 16,300 crores (US$1.9bn) of revenue in FY25, with stated plans to achieve Rs 25,000 crores revenue by FY27, with 7% EBITDA margin," the company filing added.
Following this transaction, Apollo Healthtech Limited will seek listing of its equity shares on the NSE and BSE, paving the way for investors to participate directly in the reorganised entity.
Additionally, Apollo disclosed an agreement signed on June 30, 2025, between Rasmeli Limited, an existing shareholder of AHL, and AHL promoter Shobana Kamineni. Rasmeli agreed to share a portion of its investment upside with the promoter and key employees, aligning interests and rewarding performance.AHEL shareholders to have direct shareholding in a combined entity. For every 100 shares of AHEL, AHEL shareholders will receive 195.2 shares of the new entity. Listing of the entity is expected in 18-21 months, the company filing said.Commenting on the development, Suneeta Reddy, Managing Director, Apollo Hospitals Enterprise, said, "This comprehensive integrated network, overlaid with a strong digital layer, will allow us to create an impact of magnitude greater than could be achieved with a single format of care. This proposal enables AHEL shareholders to gain direct shareholding in India's largest Omni-Channel Pharmacy and Digital Health Platform, enabling full value discovery and eliminating any hold co discount in valuation.
Meanwhile, AHEL will continue its focus on healthcare delivery, she added.
(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)
